We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid Immunopurification Technique Enables Accurate Determination of Mitochondrial Metabolites

By LabMedica International staff writers
Posted on 14 Sep 2016
A rapid immunopurification technique was used to isolate mitochondria with metabolite contents that were relatively undamaged by enzyme activity and free from components of other cellular organelles.

While metabolite profiling by mass spectrometry has been widely applied for research purposes at the whole-cell level, it is not routinely possible to measure the concentrations of small molecules in mammalian organelles. More...
However, in a recent development in this field, investigators at the Whitehead Institute (Cambridge, MA, USA) have developed a method for the rapid and specific isolation of mitochondria that allows accurate quantification of this organelle's metabolite content.

Up to now, various methods of differential centrifugation have been used to isolate mitochondria. Unfortunately, these protocols also precipitate non-mitochondrial material and other organelles. In addition, these relatively lengthy procedures promote enzymatic modifications of mitochondrial metabolites that lead to variable results.

The investigators described a novel immunopurification technique for isolation of mitochondria in the August 25, 2016, issue of the journal Cell. The method was based on antibody-covered beads that bound to specific mitochondrial surface markers. Recovery of antibody-bead-mitochondria complexes permitted rapid disruption of the mitochondria and inhibition of all enzymatic activity within 10 minutes. The immunopurification technique was used it in tandem with a database of predicted mitochondrial metabolites ("MITObolome") to measure the matrix concentrations of more than 100 metabolites across various states of mitochondrial respiratory chain (RC) function.

"The advantage of this new method is that it offers a combination of both increased speed and specificity," said senior author Dr. David Sabatini, professor of biology at the Whitehead Institute. "We are quite excited about applying this workflow in vivo and to other organelles such as lysosomes."

Related Links:
Whitehead Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Hematology Consumables
Bioblood Devices
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.